Anti-NMI functional antibody
Anti-NMI functional antibody for cell culture, ELISA & in-vivo assay
Go to NMI/NMI products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1126-Ab-1/ GM-Tg-hg-SE1126-Ab-2 | Anti-Human NMI monoclonal antibody | Human |
| GM-Tg-rg-SE1126-Ab-1/ GM-Tg-rg-SE1126-Ab-2 | Anti-Rat NMI monoclonal antibody | Rat |
| GM-Tg-mg-SE1126-Ab-1/ GM-Tg-mg-SE1126-Ab-2 | Anti-Mouse NMI monoclonal antibody | Mouse |
| GM-Tg-cynog-SE1126-Ab-1/ GM-Tg-cynog-SE1126-Ab-2 | Anti-Cynomolgus/ Rhesus macaque NMI monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1126-Ab-1/ GM-Tg-felg-SE1126-Ab-2 | Anti-Feline NMI monoclonal antibody | Feline |
| GM-Tg-cang-SE1126-Ab-1/ GM-Tg-cang-SE1126-Ab-2 | Anti-Canine NMI monoclonal antibody | Canine |
| GM-Tg-bovg-SE1126-Ab-1/ GM-Tg-bovg-SE1126-Ab-2 | Anti-Bovine NMI monoclonal antibody | Bovine |
| GM-Tg-equg-SE1126-Ab-1/ GM-Tg-equg-SE1126-Ab-2 | Anti-Equine NMI monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE1126-Ab-1/ GM-Tg-hg-SE1126-Ab-2; GM-Tg-rg-SE1126-Ab-1/ GM-Tg-rg-SE1126-Ab-2; GM-Tg-mg-SE1126-Ab-1/ GM-Tg-mg-SE1126-Ab-2; GM-Tg-cynog-SE1126-Ab-1/ GM-Tg-cynog-SE1126-Ab-2; GM-Tg-felg-SE1126-Ab-1/ GM-Tg-felg-SE1126-Ab-2; GM-Tg-cang-SE1126-Ab-1/ GM-Tg-cang-SE1126-Ab-2; GM-Tg-bovg-SE1126-Ab-1/ GM-Tg-bovg-SE1126-Ab-2; GM-Tg-equg-SE1126-Ab-1/ GM-Tg-equg-SE1126-Ab-2 |
| Products Name | Anti-NMI monoclonal antibody |
| Format | mab |
| Target Name | NMI |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-NMI benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-SE1126-Ag-1 | Recombinant multi-species NMI protein |
| ORF Viral Vector | pGMLP003879 | human NMI Lentivirus plasmid |
| ORF Viral Vector | pGMLP001279 | human NMI Lentivirus plasmid |
| ORF Viral Vector | vGMLP003879 | human NMI Lentivirus particle |
| ORF Viral Vector | vGMLP001279 | human NMI Lentivirus particle |
| ORF Viral Vector | pGMLPm001000 | mouse Nmi Lentivirus plasmid |
| ORF Viral Vector | vGMLPm001000 | mouse Nmi Lentivirus particle |
Target information
| Target ID | GM-SE1126 |
| Target Name | NMI |
| Gene ID | 9111,64685,311021,694554,476146,101100404,511280,100050154 |
| Gene Symbol and Synonyms | NMI |
| Uniprot Accession | Q13287,Q3ZCL3 |
| Uniprot Entry Name | NMI_HUMAN,NMI_BOVIN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000123609 |
| Target Classification | N/A |
The target: NMI, gene name: NMI, also named as . NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.

